Hypermarcas (HYPE3)

HYPE3 · Health Care · Brazil Brazil

Hypermarcas (HYPE3) is a company in the Health Care sector, based in Brazil. The stock is held in 1 ETF we track – with its largest weight of 0.01 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in Hypermarcas.

How many funds hold this stock?

Low ETF coverage: 1 of the 95 ETFs we cover holds Hypermarcas, spread across one index. That places it among the least widely held names in index funds — of the 4,334 stocks we cover, none sits in fewer ETFs.

The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.

Data note 1

Held in1 ETF
Highest weight0.01 %
Indices1
SectorHealth Care
CountryBrazil

Data note 2

What ETF is Hypermarcas in?

What ETF is Hypermarcas in
ETFIndexWeightper €1,000 in the ETF
IS3Nmsci-em-imi0.01 %€0.10

Data note 3

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Hypermarcas as of the fund's latest holdings list.

Weight in IS3N since 2019

Sep 30, 2019Sep 18, 2026

In IS3N, a fund tracking the MSCI EM IMI, Hypermarcas had a weight of 0.05 % on Sep 30, 2019 and 0.01 % on Sep 18, 2026. Its share peaked at 0.05 % on Sep 30, 2019. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 4

How much Hypermarcas overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Hypermarcas — the figure counts the ETFs holding both.

Stocks with similar ETF exposure
StockTickerShared ETFsr
Hapvida ParticipacoesHAPV31
Shandong Weigao GP Medical Polymer10661
Hanmi Pharm Ltd.1289401
Liga Chem Bio Inc.1410801
Jinxin Fertility Group19511
Ssy Group Ltd.20051
Saudi Pharmaceutical Indust and Me20701
Microport Neurotech Corp.21721

Data note 5

Latest Investment Analysis: Stocks